WO2010087964A3 - Composition pour le traitement et la prévention de l'acné, procédés de fabrication des compositions, et procédés d'utilisation associés - Google Patents
Composition pour le traitement et la prévention de l'acné, procédés de fabrication des compositions, et procédés d'utilisation associés Download PDFInfo
- Publication number
- WO2010087964A3 WO2010087964A3 PCT/US2010/000236 US2010000236W WO2010087964A3 WO 2010087964 A3 WO2010087964 A3 WO 2010087964A3 US 2010000236 W US2010000236 W US 2010000236W WO 2010087964 A3 WO2010087964 A3 WO 2010087964A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- compositions
- acne
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/21—Emulsions characterized by droplet sizes below 1 micron
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Birds (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des procédés permettant de traiter et de prévenir l'acné ou l'infection à P. acnes chez un sujet comprenant l'administration topique au sujet en ayant besoin d'une nanoémulsion anti-acnéique.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2750233A CA2750233A1 (fr) | 2009-01-28 | 2010-01-28 | Composition pour le traitement et la prevention de l'acne, procedes de fabrication des compositions, et procedes d'utilisation associes |
EP10703377A EP2391342A2 (fr) | 2009-01-28 | 2010-01-28 | Composition pour le traitement et la prévention de l'acné, procédés de fabrication des compositions, et procédés d'utilisation associés |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14796009P | 2009-01-28 | 2009-01-28 | |
US61/147,960 | 2009-01-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010087964A2 WO2010087964A2 (fr) | 2010-08-05 |
WO2010087964A3 true WO2010087964A3 (fr) | 2011-06-16 |
Family
ID=42077664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2010/000236 WO2010087964A2 (fr) | 2009-01-28 | 2010-01-28 | Composition pour le traitement et la prévention de l'acné, procédés de fabrication des compositions, et procédés d'utilisation associés |
Country Status (4)
Country | Link |
---|---|
US (1) | US20100226983A1 (fr) |
EP (1) | EP2391342A2 (fr) |
CA (1) | CA2750233A1 (fr) |
WO (1) | WO2010087964A2 (fr) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
JP2010528981A (ja) | 2006-12-01 | 2010-08-26 | アンテリオス, インコーポレイテッド | 両親媒性実体ナノ粒子 |
BRPI0719732A2 (pt) | 2006-12-01 | 2017-05-16 | Anterios Inc | nanopartículas de peptídeo e usos para as mesmas |
KR20150028856A (ko) | 2007-05-31 | 2015-03-16 | 안테리오스, 인코퍼레이티드 | 핵산 나노입자 및 이의 용도 |
US9814422B2 (en) | 2007-08-06 | 2017-11-14 | The Regents Of The University Of California | Compositions for solubilizing cells and/or tissue |
US20110082216A1 (en) * | 2009-10-02 | 2011-04-07 | Wu Jeffrey M | Benzoyl peroxide composition for treating skin |
SG193971A1 (en) * | 2011-01-24 | 2013-11-29 | Anterios Inc | Compositions of empty nanoparticles and their use for treating dermatological conditions |
CN102166270A (zh) * | 2011-04-06 | 2011-08-31 | 西北农林科技大学 | 一种水包油型陈皮油纳米乳及其制备方法 |
SE1300709A1 (sv) * | 2013-11-14 | 2015-05-15 | Lipidor Ab | Komposition och metod för topikal behandling |
JP6205360B2 (ja) | 2011-08-22 | 2017-09-27 | ナノバイオ コーポレーション | 単純ヘルペスウイルスのナノエマルジョンワクチン |
WO2013036907A1 (fr) | 2011-09-09 | 2013-03-14 | Nanobio Corporation | Vaccin sous-unitaire contre le virus respiratoire syncytial (rsv) en nano-émulsion |
EP2763668A4 (fr) * | 2011-10-05 | 2015-04-15 | Douglas Pharmaceuticals Ltd | Procédés pharmaceutiques et compositions topiques contenant de l'acitrétine |
CN102526163A (zh) * | 2011-12-27 | 2012-07-04 | 浙江景岳堂药业有限公司 | 一种用于风痛灵中乳香和没药的提取方法 |
WO2013130535A1 (fr) * | 2012-02-27 | 2013-09-06 | Newgen Biopharma Corporation | Administration locale de nano-formulations hormonale et non hormonale, procédés pour leur fabrication et leur utilisation |
MX369625B (es) * | 2012-05-16 | 2019-11-14 | Univ California | Composiciones para solubilizar celulas y/o tejido. |
WO2013191565A1 (fr) * | 2012-06-18 | 2013-12-27 | Waikatolink Limited | Composition antimicrobienne et son procédé d'utilisation |
GB2503235A (en) * | 2012-06-20 | 2013-12-25 | Quest Vitamins Ltd | Synergistic composition for minimising bacterial infection in animals |
US9861670B2 (en) | 2013-03-13 | 2018-01-09 | Santalis Healthcare Corporation | Stabilized cream formulations comprising sandalwood oil |
GB201313803D0 (en) * | 2013-08-01 | 2013-09-18 | Omex Agriculture Ltd | Fungicidal composition and method |
DE102014102400A1 (de) * | 2014-02-25 | 2015-08-27 | Reinhard Caliebe | Topische kosmetische oder pharmazeutische Zusammensetzung |
CN104738032B (zh) * | 2015-02-12 | 2017-03-08 | 河南科技学院 | 一种氯甲酚纳米乳消毒剂及其制备方法 |
KR102132543B1 (ko) * | 2015-06-19 | 2020-07-09 | 글로벌 헬스 솔루션즈, 엘엘씨 | 양이온성 살생물제를 포함하는 페트롤라툼-계 조성물 |
KR20170003414A (ko) * | 2015-06-30 | 2017-01-09 | (주)아모레퍼시픽 | 속붕해형 과립환 모발 세정용 조성물 |
US20190000761A1 (en) * | 2015-07-31 | 2019-01-03 | Nanobio Corporation | Methods of treating acne using nanoemulsion compositions |
WO2017062631A1 (fr) | 2015-10-07 | 2017-04-13 | Santalis Pharmaceuticals, Inc. | Essence de santal et ses utilisations liées à la mucosite buccale |
MX2019005833A (es) | 2016-11-21 | 2019-10-30 | Eirion Therapeutics Inc | Administracion transdermica de agentes grandes. |
KR102679493B1 (ko) | 2017-01-31 | 2024-07-01 | 킴벌리-클라크 월드와이드, 인크. | 벤조산 에스테르를 포함하는 항균 조성물 및 이를 이용한 세균 생장 억제 방법 |
BR112020005802A8 (pt) | 2017-09-26 | 2022-07-26 | Currahee Holding Company Inc | Composição tópica e método para tratamento e prevenção de dermatite atópica e infecções relacionadas a biofilme de bactéria |
EP3880173A1 (fr) | 2018-11-15 | 2021-09-22 | Bluewillow Biologics, Inc. | Compositions de nano-émulsion présentant une perméabilité améliorée |
US11369578B2 (en) | 2018-11-15 | 2022-06-28 | Bluewillow Biologics, Inc. | Persistent topical antimicrobial compositions and methods of using the same |
CN109541118A (zh) * | 2018-12-27 | 2019-03-29 | 江苏艾兰得营养品有限公司 | 一种能快速直观鉴别杜松子提取物的方法 |
WO2021022045A1 (fr) | 2019-07-31 | 2021-02-04 | Ecolab Usa Inc. | Compositions de détartrage sans équipement de protection individuelle |
WO2021087051A1 (fr) * | 2019-10-30 | 2021-05-06 | Ps Therapy Ltd. | Compositions topiques et leurs procédés d'utilisation |
CN114099440B (zh) * | 2021-12-08 | 2023-06-13 | 中国药科大学 | 一种装载疏水性抗氧化药物的传递体局部药物递送系统 |
WO2024002892A1 (fr) * | 2022-06-29 | 2024-01-04 | Unilever Ip Holdings B.V. | Composition anti-acné |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5549901A (en) * | 1994-05-20 | 1996-08-27 | Novavax, Inc. | Antimicrobial oil-in-water emulsions |
US20020119207A1 (en) * | 1999-04-28 | 2002-08-29 | The Regent Of The University Of Michigan | Non-toxic antimicrobial compositions and methods of use |
US20050208083A1 (en) * | 2003-06-04 | 2005-09-22 | Nanobio Corporation | Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof |
US20070243132A1 (en) * | 2005-12-22 | 2007-10-18 | Apollo Life Sciences Limited | Transdermal delivery of pharmaceutical agents |
WO2009158687A1 (fr) * | 2008-06-26 | 2009-12-30 | Anterios, Inc. | Administration dermique |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4895452A (en) | 1988-03-03 | 1990-01-23 | Micro-Pak, Inc. | Method and apparatus for producing lipid vesicles |
US5103497A (en) | 1989-11-14 | 1992-04-07 | Hicks John W | Flying spot endoscope |
AU641466B2 (en) * | 1990-01-19 | 1993-09-23 | Shiseido Company Ltd. | Dermatologic preparation |
JP2937667B2 (ja) * | 1992-11-19 | 1999-08-23 | 高砂香料工業株式会社 | 尋常性ざ瘡用皮膚外用剤 |
US6015832A (en) * | 1997-12-31 | 2000-01-18 | The Regents Of The University Of Michigan | Methods of inactivating bacteria including bacterial spores |
US6506803B1 (en) * | 1999-04-28 | 2003-01-14 | Regents Of The University Of Michigan | Methods of preventing and treating microbial infections |
US7767216B2 (en) | 1999-04-28 | 2010-08-03 | The Regents Of The University Of Michigan | Antimicrobial compositions and methods of use |
US6559189B2 (en) | 1999-04-28 | 2003-05-06 | Regents Of The University Of Michigan | Non-toxic antimicrobial compositions and methods of use |
EP1263421B1 (fr) | 2000-02-02 | 2005-05-18 | Warner-Lambert Company LLC | Le double inhibiteur de la synthese d'ester de choslesteryle et d'ester de cire avasimibe pour le traitement des troubles des glandes sebacees |
EP2545937A1 (fr) * | 2001-06-05 | 2013-01-16 | The Regents Of The University Of Michigan | Vaccins en nanoémulsion |
WO2005030172A1 (fr) | 2003-09-24 | 2005-04-07 | The Regents Of The University And Methods | Compositions antimicrobiennes en nanoemulsion et methodes associees |
EP1871349A1 (fr) * | 2005-04-11 | 2008-01-02 | Nanobio Corporation | Halogenures d'ammonium quaternaires pour le traitement de pathologies infectieuses |
US20070036831A1 (en) * | 2005-08-09 | 2007-02-15 | Nanobio Corporation | Nanoemulsion compositions having anti-inflammatory activity |
-
2010
- 2010-01-28 CA CA2750233A patent/CA2750233A1/fr not_active Abandoned
- 2010-01-28 WO PCT/US2010/000236 patent/WO2010087964A2/fr active Application Filing
- 2010-01-28 EP EP10703377A patent/EP2391342A2/fr not_active Withdrawn
- 2010-01-28 US US12/656,421 patent/US20100226983A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5549901A (en) * | 1994-05-20 | 1996-08-27 | Novavax, Inc. | Antimicrobial oil-in-water emulsions |
US20020119207A1 (en) * | 1999-04-28 | 2002-08-29 | The Regent Of The University Of Michigan | Non-toxic antimicrobial compositions and methods of use |
US20050208083A1 (en) * | 2003-06-04 | 2005-09-22 | Nanobio Corporation | Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof |
US20070243132A1 (en) * | 2005-12-22 | 2007-10-18 | Apollo Life Sciences Limited | Transdermal delivery of pharmaceutical agents |
WO2009158687A1 (fr) * | 2008-06-26 | 2009-12-30 | Anterios, Inc. | Administration dermique |
Also Published As
Publication number | Publication date |
---|---|
EP2391342A2 (fr) | 2011-12-07 |
US20100226983A1 (en) | 2010-09-09 |
WO2010087964A2 (fr) | 2010-08-05 |
CA2750233A1 (fr) | 2010-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010087964A3 (fr) | Composition pour le traitement et la prévention de l'acné, procédés de fabrication des compositions, et procédés d'utilisation associés | |
WO2009089494A3 (fr) | Compositions pharmaceutiques | |
WO2012092336A3 (fr) | Profilage moléculaire pour le cancer | |
WO2009129246A3 (fr) | Compositions et leurs procédés de préparation et d'utilisation | |
WO2012024620A3 (fr) | Inhibiteurs de l'autotaxine et leurs utilisations | |
MX2011009539A (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso. | |
WO2009155513A3 (fr) | Immunoglobulines présentant une agrégation réduite | |
IN2012DN00624A (fr) | ||
WO2012170807A3 (fr) | Molécules de liaison anti-psl de pseudomonas et leurs utilisations | |
WO2009039337A3 (fr) | Inhibition de l'angiogenèse | |
WO2010088450A3 (fr) | Procédés de traitement de maladies associées à la modulation de serca | |
WO2012012278A3 (fr) | Compositions et procédés pour le traitement de troubles pathologiques associés à gpr35 et/ou au complexe gpr35-herg | |
WO2010097788A3 (fr) | Agents thérapeutiques de visfatine pour traiter l'acné et d'autres conditions | |
UA107687C2 (ru) | Комбинированная композиция, которая в качестве активных ингредиентов содержит l-карнитин или пропионил-l-карнитин, троксерутин, диосмин и гесперидин, для предотвращения и/или лечения хронических заболеваний вен. | |
WO2010032011A3 (fr) | Thérapie antifongique | |
WO2011042902A3 (fr) | Microcapsules comprenant du peroxyde de benzoyle et compositions topiques comprenant celles-ci | |
WO2012053013A3 (fr) | Compositions pharmaceutiques d'agents anti-acné | |
WO2009090394A3 (fr) | Composition pour traiter un trouble de la peau | |
WO2011150457A3 (fr) | Inhibiteurs de la prostaglandine d2 synthase hématopoïétique | |
WO2010021750A3 (fr) | Procédés et compositions pour l'administration de 3-halopyruvate et de composés associés pour le traitement du cancer | |
WO2009155070A3 (fr) | Compositions et procédés pour le traitement d’inflammation et de lésions hyperkératotiques | |
WO2013096335A8 (fr) | Administration d'un antagoniste de l'intégrine alpha-5-bêta 1 afin de lutter contre l'angiogenèse et de traiter le cancer | |
WO2013000895A9 (fr) | Dha et epa pour la réduction du stress oxydatif | |
WO2010042212A3 (fr) | Méthodes de traitement prophylactique ou thérapeutique de la douleur à l'aide de dérivés de spicamycine | |
WO2010051138A3 (fr) | Traitements cutanés contenant des dérivés d'idébénone substituée par un acide carboxylique et procédés pour les préparer et les utiliser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10703377 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2750233 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010703377 Country of ref document: EP |